DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Huillard O, Jouinot A, Tlemsani C. et al.
Body composition in patients with radioactive iodine-refractory, advanced
differentiated thyroid cancer treated with sorafenib or placebo: A retrospective
analysis of the Phase III DECISION Trial.
Thyroid 2019;
29: 1820-1827
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.